MML INVESTORS SERVICES, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 79 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
MML INVESTORS SERVICES, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$104
+33.3%
54,2270.0%0.00%
Q2 2023$78
-32.2%
54,227
-1.0%
0.00%
-100.0%
Q1 2023$115
+85.5%
54,7770.0%0.00%
Q4 2022$62
-99.9%
54,777
+10.0%
0.00%
-100.0%
Q3 2022$81,000
+58.8%
49,777
+28.4%
0.00%
Q2 2022$51,000
-17.7%
38,7770.0%0.00%
Q1 2022$62,000
-11.4%
38,777
+14.8%
0.00%
-100.0%
Q4 2021$70,000
-41.7%
33,777
+9.6%
0.00%0.0%
Q3 2021$120,000
+21.2%
30,8180.0%0.00%0.0%
Q2 2021$99,000
+47.8%
30,8180.0%0.00%0.0%
Q1 2021$67,000
-2.9%
30,8180.0%0.00%0.0%
Q4 2020$69,000
-9.2%
30,818
+8.0%
0.00%0.0%
Q3 2020$76,000
-12.6%
28,5410.0%0.00%0.0%
Q2 2020$87,000
+55.4%
28,5410.0%0.00%0.0%
Q1 2020$56,000
-11.1%
28,541
+28.9%
0.00%0.0%
Q4 2019$63,000
-22.2%
22,1410.0%0.00%0.0%
Q3 2019$81,000
-31.9%
22,141
-23.1%
0.00%
-50.0%
Q2 2019$119,000
+12.3%
28,793
+38.5%
0.00%0.0%
Q1 2019$106,000
+15.2%
20,784
-22.8%
0.00%0.0%
Q4 2018$92,000
-11.5%
26,926
+55.8%
0.00%0.0%
Q3 2018$104,000
-20.0%
17,284
-15.7%
0.00%
-33.3%
Q2 2018$130,000
+56.6%
20,511
+16.6%
0.00%
+50.0%
Q1 2018$83,000
-8.8%
17,594
-35.3%
0.00%0.0%
Q4 2017$91,000
+279.2%
27,213
+138.9%
0.00%
Q3 2017$24,00011,3910.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$271,9250.08%
Geneos Wealth Management Inc. 427,400$897,5400.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$25,2000.02%
Vivaldi Capital Management LP 19,261$40,4480.01%
Beacon Capital Management, LLC 12,605$26,4710.01%
Atria Wealth Solutions, Inc. 263,300$552,9300.01%
Wealthspire Advisors, LLC 183,862$386,1110.01%
BARRETT & COMPANY, INC. 4,984$10,4660.01%
OSAIC HOLDINGS, INC. 1,271,760$2,670,6560.01%
Ameritas Advisory Services, LLC 45,302$94,8560.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders